Table 4 Grade 3 ≤ adverse events during the second-line chemotherapy
Adverse event | BBP group (%) | Non-BBP group (%) |
|---|---|---|
Hematological | ||
 Neutropenia | 6 (16.2) | 6 (24.0) |
 Anemia | 1 (2.7) | 4 (16.0) |
 Thrombocytopenia | 1 (2.7) | 1 (4.0) |
Non-hematological | ||
 Fatigue | 0 (0) | 1 (4.0) |
 Decreased appetite | 2 (5.4) | 2 (8.0) |
 Diarrhea | 2 (5.4) | 0 (0) |
 Hypertension | 1 (2.7) | 0 (0) |
 Proteinuria | 1 (2.7) | 0 (0) |
 Gastrointestinal perforation | 1 (2.7) | 1 (4.0) |
 Bleeding | 1 (2.7) | 1 (4.0) |
 Venous thromboembolic | 1 (2.7) | 0 (0) |
 Cerebral infarction | 1 (2.7) | 0 (0) |
 Ileus | 1 (2.7) | 1 (4.0) |
 Hepatic infection | 0 (0) | 1 (4.0). |
 Febrile neutropenia | 1 (2.7) | 0 (0) |